Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock
Journal of Thrombosis and Haemostasis · 2024
DOI: 10.1016/j.jtha.2023.11.018 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Henry Schofield und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, London, United Kingdom; Barts Health National Health Service Trust, L…. Hauptthemen laut MEDLINE: Blood Coagulation Disorders, Shock, Hemorrhagic, Wounds and Injuries. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: ABO blood group alters coagulation profiles in the general population and may influence outcomes after trauma. The relationship between trauma-induced coagulopathy, severe injury with hemorrhagic shock, and survival with respect to ABO group is unknown. OBJECTIVES: In severe hemorrhagic trauma, we aimed to characterize the association of ABO group with admission coagulation profiles, mortality, and immune-mediated complications. METHODS: Clinical and laboratory variables were examined from severely injured adult patients enrolled in a perpetual observational cohort study at a UK Major Trauma Center. Univariate and multivariate analyses were performed to determine differences in clinical outcomes (mortality, organ dysfunction, and critical care support). In a shock subgroup, we performed an exploratory analysis of rotational thromboelastometry parameters and coagulation biomarkers. RESULTS: In 1119 trauma patients, we found no difference in mortality between ABO groups. In patients with shock, 24-hour mortality was significantly lower in group B vs non-B groups (7% vs 16%, adjusted odds ratio [aOR], 0.19; P = .030), but there were increased rates of invasive ventilation (aOR, 3.34; P = .033), renal replacement therapy (aOR, 2.55; P = .037), and a trend for infection (aOR, 1.85; P = .067). Comparing patients with shock, group B vs non-B patients had 40% higher fibrinogen, 65% higher factor (F) VIII, 36% higher FIX, 20% higher FXIII, and 19% higher von Willebrand factor. CONCLUSION: In this observational study limited by single time-point sampling and subgroup analysis of trauma hemorrhage with shock, group B patients have enhanced hemostatic capability associated with early survival but with increased risk of immune-mediated complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, London, United Kingdom; Barts Health National Health Service Trust, London, United Kingdom. Electronic address: henry.schofield@nhs.net.
- Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, London, United Kingdom; Barts Health National Health Service Trust, London, United Kingdom.
Zitieren
APA
Schofield, H., Lindsay, C., Brohi, K., & Davenport, R. (2024). Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2023.11.018
Vancouver
Schofield H, Lindsay C, Brohi K, Davenport R. Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2023.11.018
BibTeX
@article{Schofield2024,
author = {Schofield, Henry and Lindsay, Charlotte and Brohi, Karim and Davenport, Ross},
title = {Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
doi = {10.1016/j.jtha.2023.11.018}
}
EUVIMED